Cargando…
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable
In the USA, an interchangeability designation provides biosimilar sponsors with a pathway for achieving what is standard for small-molecule generics: pharmacy-level auto-substitution for an innovator. No other major health authority links interchangeability to automatic substitution, as all require...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107170/ https://www.ncbi.nlm.nih.gov/pubmed/33745111 http://dx.doi.org/10.1007/s12325-021-01688-9 |